Producer of drug-spiked products masquerading as dietary supplements sentenced in federal court (FDA)

AHPA Alerts

AHPA Alerts

AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.

Subscribe

View recent alerts:

  • Legal Alerts News on dietary supplement laws, regulations and enforcement
  • Science Alerts The latest research on herbs and botanicals
  • Market Alerts Herbal market trends and AHPA-member press releases
  • Media Alerts Media coverage of the herbal industry 
  • Cannabis Alerts The latest research and news about hemp, CBD and medical marijuana
  • Cosmetic Alerts Regulatory updates and personal care product news

Subscribe to AHPA Updates to stay informed about the latest AHPA news and resources.

Recent News

Producer of drug-spiked products masquerading as dietary supplements sentenced in federal court (FDA)

Published: Tuesday, June 24, 2014

Editor's Note: The owner and CEO of Balanced Health Products (BHP) was fined $60,000 for distributing drug-spiked products masquerading as dietary supplements. BHP advertised StarCaps as weight-loss pills containing only all-natural ingredients, but the pills also contained the prescription drug bumetanide. Agents from the FDA's Office of Criminal Investigations, New York Field Office spearheaded the investigation, which led to the permanent removal of this tainted dietary supplement from the market. BHP's owner says  the company is now defunct and has filed for bankruptcy.

 Food and Drug Administration

Producer of tainted dietary supplements sentenced in federal court    

Nikki Haskell, the owner and chief executive officer of Balanced Health Products (BHP), has been sentenced by a United States magistrate judge in Manhattan federal court to a $60,000 fine for distributing dietary supplements that contained a prescription drug.

From at least November 2006 through December 2008, BHP's primary business was the distribution across the United States of this product, called "Nikki Haskell's StarCaps" (StarCaps).

BHP advertised StarCaps as weight-loss pills containing only all-natural ingredients including, for example, papaya extract. The company failed to list on the product's label that the pills also contained bumetanide, a powerful diuretic used clinically to treat heart failure, kidney failure, high blood pressure and swelling (edema). Bumetanide is available in the United States only by prescription from a licensed physician.

In March 2014, Haskell was convicted upon a guilty plea to distributing the misbranded StarCaps from BHP's New York City-based location. Per Haskell, the company is now defunct and has filed for bankruptcy.

Agents from the FDA's Office of Criminal Investigations, New York Field Office spearheaded this investigation, which led to the permanent removal of this tainted dietary supplement from the market.

"There is a strict regulatory process in the United States for the distribution and dispensing of prescription drugs, and dietary supplements cannot legally contain such drugs," said Philip Walsky, acting director of the FDA's Office of Criminal Investigations. "Consumers rely on the labels of dietary supplements to inform them about any potential health risks. The FDA will continue its vigilance over the dietary supplement market."

Use of bumetanide is banned by certain professional sports organizations, including the National Football League, in part because bumetanide can mask the presence in the human body of steroids and other banned doping agents  

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, and products that give off electronic radiation, and for regulating tobacco products.

[READ MORE...]

The links above is provided as a convenience, however, web pages are often updated by their host sites, and this link may not remain active. AHPA gathers information from many organizations. Some sites may require you to register, subscribe, or pay a fee in order to obtain the full article.

Print

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.